HCW BIOLOGICS INC's ticker is and the CUSIP is 40423R105. A total of 14 filers reported holding HCW BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,668 | -15.9% | 47,720 | -4.0% | 0.00% | – |
| Q2 2023 | $107,821 | +74.6% | 49,687 | +12.8% | 0.00% | – |
| Q1 2023 | $61,736 | -24.4% | 44,066 | +3.3% | 0.00% | – |
| Q4 2022 | $81,655 | -14.9% | 42,644 | +2.3% | 0.00% | – |
| Q3 2022 | $96,000 | +2.1% | 41,696 | -2.8% | 0.00% | – |
| Q2 2022 | $94,000 | -13.0% | 42,881 | +8.3% | 0.00% | – |
| Q1 2022 | $108,000 | +176.9% | 39,583 | +136.8% | 0.00% | – |
| Q4 2021 | $39,000 | -25.0% | 16,714 | +2.7% | 0.00% | – |
| Q3 2021 | $52,000 | – | 16,279 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 82,600 | $157,766 | 0.00% |
| HighTower Advisors, LLC | 354,869 | $675,000 | 0.00% |
| Cresset Asset Management, LLC | 131,990 | $250,781 | 0.00% |
| Focused Wealth Management, Inc | 1,000 | $1,900 | 0.00% |
| UBS Group AG | 212 | $403 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 22,840 | $43,396 | 0.00% |
| WELLS FARGO & COMPANY/MN | 131 | $249 | 0.00% |
| NORTHERN TRUST CORP | 10,205 | $19,390 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 132,503 | $253,171 | 0.00% |